A. Knol

发表

PD‐L1 expression by tumor cell lines: A predictive marker in melanoma

B. Dréno, M. Denis, A. Khammari, 2018, Experimental Dermatology.

Induction of toll‐like receptors by Propionibacterium acnes

B. Dréno, A. Khammari, G. Quéreux, 2005, The British journal of dermatology.

Is a single BRAF wild-type test sufficient to exclude melanoma patients from vemurafenib therapy?

B. Dréno, M. Denis, A. Khammari, 2014, The Journal of investigative dermatology.

Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients

B. Dréno, M. Denis, P. Hofman, 2020, Cancers.

Incidence and characteristics of melanoma brain metastases developing during treatment with vemurafenib

B. Dréno, A. Khammari, G. Quéreux, 2014, Journal of Neuro-Oncology.

Profile of vemurafenib‐induced severe skin toxicities

B. Dréno, A. Khammari, G. Quéreux, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Immunohistochemical markers of advanced basal cell carcinoma: CD56 is associated with a lack of response to vismodegib

B. Dréno, A. Khammari, J. Nguyen, 2016, European Journal of Dermatology.

Tissue Biomarkers in Melanoma Patients Treated with TIL

B. Dréno, A. Khammari, G. Quéreux, 2012, PloS one.

[Melanoma: Cellular and vaccinal immunotherapy].

B. Dréno, A. Khammari, N. Labarrière, 2014, Bulletin de l'Academie nationale de medecine.

Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature.

B. Dréno, A. Khammari, G. Quéreux, 2013, Journal of the American Academy of Dermatology.

Absence of amplification of CD4+CD25high regulatory T cells during in vitro expansion of tumor‐infiltrating lymphocytes in melanoma patients

C. Volteau, A. Khammari, F. Lemaı̂tre, 2008, Experimental dermatology.

Tight junction proteins in the canine epidermis: a pilot study on their distribution in normal and in high IgE-producing canines.

V. Bruet, P. Bourdeau, R. Marsella, 2015, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation.

B. Dréno, A. Khammari, J. Nguyen, 2011, The Journal of investigative dermatology.

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy

B. Dréno, M. Denis, S. Théoleyre, 2018, Oncotarget.

Zinc gluconate is an agonist of peroxisome proliferator‐activated receptor‐α in the epidermis

B. Dréno, A. Khammari, G. Quéreux, 2012, Experimental dermatology.

Absence of modulation of CD4+CD25high regulatory T cells in CTCL patients treated with bexarotene

B. Dréno, A. Khammari, G. Quéreux, 2009, Experimental dermatology.

Optimization of an immunohistochemical method to assess distribution of tight junction proteins in canine epidermis and adnexae.

V. Bruet, P. Bourdeau, A. Knol, 2014, Journal of comparative pathology.

Tissue Prognostic Factors in Melanoma: Expression of B7 Family Members B7-H3 and B7-H4 and Death Receptors TRAIL-R1 and TRAILR2

B. Dréno, A. Khammari, G. Quéreux, 2012 .

Prognostic value of tumor‐infiltrating Foxp3+ T‐cell subpopulations in metastatic melanoma

B. Dréno, A. Khammari, G. Quéreux, 2011, Experimental dermatology.

Pathogenetic mechanisms of vitiligo in a patient with Sézary syndrome

B. Dréno, A. Khammari, G. Quéreux, 2005, The British journal of dermatology.

Histopathological aspects of cutaneous erythematous‐papular eruptions induced by immune checkpoint inhibitors for the treatment of metastatic melanoma

B. Dréno, A. Khammari, A. Knol, 2017, International journal of dermatology.

Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab

B. Dréno, A. Khammari, G. Quéreux, 2015, Journal of Neuro-Oncology.

Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study

B. Dréno, M. Denis, S. Théoleyre, 2021, Cancers.

Clinical, Genetic and Innate Immunity Characteristics of Melanoma in Organ Transplant Recipients.

B. Dréno, M. Denis, J. Dantal, 2017, Acta dermato-venereologica.

Effect of indoleamine 2,3‐dioxygenase expressed by foetal fibroblasts on melanoma cells

B. Dréno, A. Khammari, A. Knol, 2016, Experimental dermatology.

Efficient Detection of BRAF Mutation in Plasma of Patients after Long-term Storage of Blood in Cell-Free DNA Blood Collection Tubes.

B. Dréno, M. Denis, S. Théoleyre, 2015, Clinical chemistry.

Hidradenitis suppurativa: the role of deficient cutaneous innate immunity.

B. Dréno, A. Khammari, D. Moyse, 2012, Archives of dermatology.

Effect of Indoleamine 2,3 Dioxygenase Inhibitor on the Cytotoxic Activity of Tumour-infiltrating Lymphocytes.

B. Dréno, A. Khammari, A. Knol, 2019, Acta dermato-venereologica.

Different strains of Propionibacterium acnes modulate differently the cutaneous innate immunity

B. Dréno, I. Nagy, A. Khammari, 2013, Experimental dermatology.

Ex vivo demonstration of a synergistic effect of Adapalene and benzoyl peroxide on inflammatory acne lesions

B. Dréno, A. Khammari, A. Knol, 2011, Experimental dermatology.

Anti-inflammatory properties of a new undecyl-rhamnoside (APRC11) against P. acnes

B. Dréno, A. Khammari, J. Nguyen, 2011, Archives of Dermatological Research.

Vorinostat for refractory or relapsing epidermotropic T-cell lymphoma: a retrospective cohort study of 15 patients.

C. Volteau, B. Dréno, G. Quéreux, 2015, Acta dermato-venereologica.

TG1042 (Adenovirus-interferon-γ) in Primary Cutaneous B-cell Lymphomas: A Phase II Clinical Trial

R. Dummer, B. Dréno, J. Limacher, 2014, PLoS ONE.

Bexarotene in cutaneous T-cell lymphoma: third retrospective study of long-term cohort and review of the literature

B. Dréno, G. Quéreux, A. Knol, 2013, Expert opinion on pharmacotherapy.

Systemic rituximab in multifocal primary cutaneous follicle centre lymphoma.

B. Dréno, G. Quéreux, J. Nguyen, 2011, Acta dermato-venereologica.

Toll‐like receptor 2, 4, 7 and 9 expression in primary cutaneous CD30+ T‐cell lymphoma

B. Dréno, A. Khammari, B. Ehst, 2009, The British journal of dermatology.

Comparison of three culture media for the establishment of melanoma cell lines

B. Dréno, A. Knol, M. Pandolfino, 2010, Cytotechnology.

Fetal Fibroblasts and Keratinocytes with Immunosuppressive Properties for Allogeneic Cell-Based Wound Therapy

B. Dréno, A. Knol, J. Esbelin, 2013, PloS one.

Evaluation of the role of human herpes virus 6 and 8 in parapsoriasis

B. Dréno, G. Quéreux, A. Knol, 2009, Experimental dermatology.

Predictive factors of response to vismodegib: a French study of 61 patients with multiple or locally advanced basal cell carcinoma

B. Dréno, A. Khammari, J. Nguyen, 2022, European Journal of Dermatology.

Cutaneous induction of corticotropin releasing hormone by Propionibacterium acnes extracts

B. Dréno, M. Charvéron, A. Khammari, 2009, Dermato-endocrinology.

About the cutaneous targets of bexarotene in CTCL patients

B. Dréno, A. Khammari, G. Quéreux, 2009, Experimental dermatology.

Hidradenitis Suppurativa and Zinc: A New Therapeutic Approach

B. Dréno, A. Khammari, A. Knol, 2007, Dermatology.

Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).

B. Dréno, A. Khammari, G. Quéreux, 2006, European journal of dermatology : EJD.

A new protoparvovirus in human fecal samples and cutaneous T cell lymphomas (mycosis fungoides).

E. Delwart, B. Dréno, K. Alexander, 2016, Virology.

Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy.

B. Dréno, V. Vignard, A. Khammari, 2017, Cancer research.

Younger age at the time of first metastasis in BRAF-mutated compared to BRAF wild-type melanoma patients.

B. Dréno, M. Denis, A. Khammari, 2014, Oncology reports.

Impact of the time interval between lymph node recurrence and lymphadenectomy on melanoma patient survival

B. Dréno, A. Khammari, J. Nguyen, 2017, European Journal of Dermatology.

Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis: a case report

B. Dréno, M. Denis, S. Théoleyre, 2017, BMC Research Notes.

Clinical significance of BRAF mutation status in circulating tumor DNA of metastatic melanoma patients at baseline

B. Dréno, M. Denis, S. Théoleyre, 2016, Experimental dermatology.

Comparative analysis of BRAF, NRAS and c‐KIT mutation status between tumor tissues and autologous tumor cell‐lines of stage III/IV melanoma

B. Dréno, M. Denis, F. Nguyen, 2015, Experimental dermatology.

Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants.

B. Dréno, G. Quéreux, A. Knol, 2010, Acta dermato-venereologica.

Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival

B. Dréno, M. Denis, A. Khammari, 2014, Journal of immunology research.

Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones.

B. Dréno, V. Vignard, A. Khammari, 2009, The Journal of investigative dermatology.

P003. TLR7 and TLR8 expression by melanoma cells correlates with a better relapse-free survival for stage III melanoma patients

B. Dréno, A. Khammari, J. Nguyen, 2011 .

Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial

B. Dréno, A. Khammari, N. Labarrière, 2020, Cancer Immunology, Immunotherapy.

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients

C. Volteau, B. Dréno, N. Basset-Seguin, 2018, Journal of immunology research.

Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients

B. Dréno, J. Limacher, A. Khammari, 2015, Cancer Immunology, Immunotherapy.

Tissue prognostic markers for adoptive immunotherapy in melanoma.

C. Volteau, B. Dréno, A. Khammari, 2007, European journal of dermatology : EJD.

CD8(+) T lymphocytes reactive against Epstein-Barr virus antigens in skin lesions of a patient with Sézary syndrome.

B. Dréno, A. Khammari, G. Quéreux, 2005, Journal of the American Academy of Dermatology.

Presence of Epstein-Barr virus in Langerhans cells of CTCL lesions.

B. Dréno, A. Khammari, G. Quéreux, 2005, The Journal of investigative dermatology.

Overexpression of MMP-2 and MMP-9 in squamous cell carcinomas of immunosuppressed patients

B. Dréno, A. Knol, S. Leroy, 2002, Archives of Dermatological Research.

BRAF mutations might be more common than supposed in vulvar melanomas

B. Dréno, M. Denis, S. Théoleyre, 2018, Experimental dermatology.

P058. Detection of HPV in situ carcinomas by in situ hybridization after photodynamic therapy

B. Dréno, G. Quéreux, A. Knol, 2011 .

TLR expression in human melanoma cells.

B. Dréno, A. Khammari, J. Nguyen, 2011, European journal of dermatology : EJD.

P002. Tissue prognostic factors in melanoma: expression of B7 family members and death receptors TRAIL-R1 and TRAIL-R2

B. Dréno, A. Khammari, J. Nguyen, 2011 .

Are checkpoint inhibitors a valuable option for metastatic or unresectable vulvar and vaginal melanomas?

B. Dréno, M. Hanf, G. Quéreux, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Efficient treatment of a metastatic melanoma patient with a combination of BRAF and MEK inhibitors based on circulating tumor DNA analysis: a case report

B. Dréno, M. Denis, S. Théoleyre, 2017, BMC Research Notes.

Human β-defensin-2 and psoriasin, two new innate immunity targets of zinc gluconate.

B. Dréno, A. Khammari, G. Quéreux, 2012, European journal of dermatology : EJD.

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy

B. Dréno, M. Denis, S. Théoleyre, 2018, Oncotarget.

Expression of Three Adipokines (Adiponectin, Leptin and Resistin) in Normal Canine Skin: a Pilot Study.

B. Dréno, A. Khammari, V. Bruet, 2019, Journal of comparative pathology.

Younger age at the time of first metastasis in BRAF-mutated compared to BRAF wild-type melanoma patients.

B. Dréno, M. Denis, A. Khammari, 2014, Oncology reports.

Circulating tumour DNA: analytical aspects and clinical applications for metastatic melanoma patients.

B. Dréno, M. Denis, S. Théoleyre, 2017, Annales de biologie clinique.

Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation.

B. Dréno, A. Khammari, J. Nguyen, 2011, The Journal of investigative dermatology.